Open-label epidemiological study of Helicobacter pylori before and after switch from MMF to Myfortic in stable renal transplant patients

Phase 3, open-label, single-arm trial of mycophenolate sodium in kidney transplant immunosuppression and Helicobacter pylori infection, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Frequency of Helicobacter pylori infection before and after switch. Started Aug 2005; status: active.